Literature DB >> 6943371

Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas.

P Allavena, M Introna, C Mangioni, A Mantovani.   

Abstract

Tumor-associated lymphocytes (TAL) were isolated from ascites ovarian tumors by stepwise application of density and velocity sedimentation on discontinuous Ficoll-Hypaque gradients and fetal bovine serum. TAL had low levels of natural killer (NK) activity compared to levels of peripheral blood lymphocytes (PBL) from the same patients or control subjects. When TAL were mixed with PBL, significant inhibition of NK activity was observed in 7 of 27 patients tested, with the suppression levels ranging from 14 to 60%. Inhibition of PBL NK activity was observed at the ratio of TAL to PBL of 1:1 or 2:1. Suppression of NK activity was detected with effector-to-target cell ratios ranging from 6:1 to 25:1 and at incubation time from 4 to 20 hours in the cytolysis assay. Tumor-associated macrophages from 6 patients were tested for suppression of NK activity. Only with 1 donor was a 17% inhibition observed at a ratio of macrophages of PBL of 1:1. Thus suppression by mature plastic adherent macrophages does not play a major role in the determination of the low levels of NK in human ascites ovarian tumors and the inhibitory activity of suppressor TAL, which had a minor contamination (less than 5%) with mononuclear phagocytes. When TAL from 1 patient with suppressive activity were passed through nylon wool, inhibition of NK activity was observed with both adherent and nonadherent cells.

Entities:  

Mesh:

Year:  1981        PMID: 6943371

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

1.  The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate.

Authors:  N Lahat; B Alexander; D R Levin; B Moskovitz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

3.  Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.

Authors:  G Feuer; S A Stewart; S M Baird; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

4.  Defective NK cell activity following thermal injury.

Authors:  G R Klimpel; D N Herndon; M Fons; T Albrecht; M T Asuncion; R Chin; M D Stein
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  Relationship of the distribution of Leu-2+ cells with suppressor cell activities in the spleen and lymph-nodes from gastric cancer.

Authors:  T Toge; Y Seto; K Kuroi; H Yamada; K Aratani; T Fujita; E Yanagawa; T Hattori
Journal:  Jpn J Surg       Date:  1987-03

6.  Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.

Authors:  E Lotzová; C A Savary; R S Freedman; J M Bowen
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 7.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  Clinical and biological effects of tumor-associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients.

Authors:  Weiwei Zhang; Kejun Liu; Bin Ye; Guolin Hu; Kelei Zhao; Yazhou Ren; Weijiang Liang
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

9.  Suppression of natural killer cell activity by adherent effusion cells of cancer patients. Suppression of motility, binding capacity and lethal hit of NK cells.

Authors:  A Uchida; M Colot; M Micksche
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

10.  Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.

Authors:  F Colotta; A Rambaldi; N Colombo; L Tabacchi; M Introna; A Mantovani
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.